Clinical Trial Update: Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating MSH2-/- tumor cell vaccines in advanced pMMR colorectal cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MSH2-/- Tumor Cell Vaccine (MSH2-/- tumor cell vaccine)

Snippet

Sponsor: West China Hospital | Conditions: pMMR/MSS Advanced Colorectal Cancer | Phase 1 | Status: RECRUITING